Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports
-
* Corresponding author: R Andrew Moore andrew.moore@pru.ox.ac.uk
Arthritis Research & Therapy 2008, 10:R53 doi:10.1186/ar2422
Accesses
- Last 30 days: 71 accesses
- Last 365 days: 703 accesses
- All time: 3617 accesses
Cited by
BioMed Central: 1 citation
|
Research article
R Andrew Moore, Helen Gaskell, Peter Rose, Jonathan Allan BMC Blood Disorders 2011, 11:4 (24 September 2011) Evidence from the literature suggests that, in line with current recommendations, intravenous ferric carboxymaltose is effective and safe in treating iron deficiency anemia in many chronic conditions, but there are limited trial data comparing different intravenous iron preparations.
|
